Rating: HOLD
| Metric | Value |
|---|---|
| Current Price | $27 |
| Triangulated Fair Value | $28 |
| 12-mo Scenario PWEV | $29 |
| Implied Return | +4% |
| Forward P/E | 9.3x |
| Market Cap | $20B |
| 52-Week Range | $19 – $42 |
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.
Investment Thesis
The bull case — 'Spike — Supply Dislocation' (8% weight) — targets $67, +145% vs spot. It needs Gross Margin to surprise to the upside.
The dashboard below is the whole argument on one page: spot ($27) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural case — 'Structural — Petrochem Overcapacity / Demand Peak' (24%) — targets $7.69, -72% vs spot. This sits below the 52-week low — a genuine structural impairment, not a mild pullback.
Key Debate
Gross Margin explains 64% of Monte Carlo outcome variance — the single variable that decides which side is right.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.39 vs analyst floor +0.00 → delta +0.39 (n=22 mgmt / 8 Q&A; 51th pctile across the S&P book, z -0.0).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.39 | +0.00 | +0.39 |
| 2025Q4 | +0.42 | +0.22 | +0.20 |
| 2025Q3 | +0.31 | +0.14 | +0.18 |
| 2025Q2 | +0.19 | +0.01 | +0.18 |
News (last 365d, 1000 articles): avg ticker sentiment +0.13 (bullish 28% / bearish 10%)
Scenario Analysis
The tree runs from a structural 'Structural — Petrochem Overcapacity / Demand Peak' downside ($8) to a 'Spike — Supply Dislocation' bull case ($67); the probability-weighted blend (PWEV $29) is +7% versus spot.
| Scenario | Probability | Target | Return |
|---|---|---|---|
| Structural — Petrochem Overcapacity / Demand Peak | 24% | $8 | -72% |
| Downturn — Trough Margins | 18% | $17 | -39% |
| Base — Mid-Cycle Spreads | 32% | $30 | +11% |
| Upcycle — Tight Spreads | 18% | $52 | +90% |
| Spike — Supply Dislocation | 8% | $67 | +145% |
| Probability-Weighted (PWEV) | — | $29 | +7% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Petrochem Overcapacity / Demand Peak (24%, $8). Structural impairment — capacity glut / demand peak: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 7.69; probability: 0.24.
- Downturn — Trough Margins (18%, $17). Cyclical downturn — petrochemical spreads (ethylene/PE/PP) + feedstock + global demand weakens for 1–2 years before normalising. Drivers — implied_target: 16.62; probability: 0.18.
- Base — Mid-Cycle Spreads (32%, $30). Mid-cycle — normalised petrochemical spreads (ethylene/PE/PP) + feedstock + global demand; disciplined capital allocation; steady returns. Drivers — implied_target: 30.45; probability: 0.32.
- Upcycle — Tight Spreads (18%, $52). Upside — supply dislocation / tight spreads lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 51.92; probability: 0.18.
- Spike — Supply Dislocation (8%, $67). Upside tail — sustained tight conditions or a structural re-rate on supply dislocation / tight spreads. Drivers — implied_target: 67.15; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $27 | -2% |
| Peer P/E re-rate | multiple | $58 | +111% |
| Peer EV/Revenue re-rate | multiple | $84 | +206% |
| Scenario PWEV | multiple | $29 | +7% |
| DCF (5-year + terminal) | cash flow + terminal × | $6 | -79% |
| Triangulated (weighted) | — | $28 | +4% |
DCF, peer P/E re-rate excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $27 and 49% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (64% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 9.5%, 8x terminal FCF multiple → $6. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 19.685000000000002x) implies $58. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is wide (genuine disagreement — low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|
| Commodity Chemicals / Petrochemicals | $39.3B | 100% | 2% | 7% | 10x | 7% | ESTIMATE |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | petrochemical spreads (ethylene/PE/PP) + feedstock + global demand |
| net_debt_or_cash_b | -15.52 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.07 |
| div_yield | 0.0577 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | capacity glut / demand peak |
| upside | supply dislocation / tight spreads |
Industry Context — Materials — Commodity
This name sits in the Materials — Commodity as a commodity_chem. petrochemical spreads (ethylene/PE/PP) + feedstock + global demand Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: DOW (commodity_chem) · LYB (commodity_chem) · ALB (lithium) · CF (fertilizer) · MOS (fertilizer)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Commodity Glut — Oversupply / Demand Reset | 42% | 42% | |
| Mid-Cycle — Normalised Prices | 32% | 32% | |
| Tight Market — Upcycle / Spike | 26% | 26% |
On the cluster's key downside — Commodity Glut — Oversupply / Demand Reset () — this name implies 42% vs the cluster house view of 42% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The commodity cycle is the shared macro driver. Driver — commodity-chemical / nutrient / lithium price cycle + feedstock costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $40B | $3B | $3B | $3B | $2B | $2B |
| FY+2 | $41B | $3B | $3B | $3B | $2B | $2B |
| FY+3 | $41B | $3B | $3B | $3B | $2B | $2B |
| FY+4 | $42B | $3B | $3B | $3B | $2B | $2B |
| FY+5 | $42B | $3B | $3B | $3B | $2B | $1B |
| Terminal | — | — | — | — | $2B × 8x | $11B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 7% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 9.5% · Σ PV(FCF) $8B + PV(terminal) $11B = EV $20B; + net cash → equity $4B ÷ diluted shares 0.72B = $6/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $19/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 2% vs WACC 10% → below WACC — the incremental build is value-dilutive.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| PKG | 2.714x | 22.68x | 3% | 14% |
| IP | 1.19x | 26.53x | 3% | 4% |
| IFF | 2.321x | 16.69x | 5% | 10% |
| AMCR | 1.55x | 10.5x | 3% | 9% |
| Median | 1.9355000000000002x | 19.685000000000002x | — | — |
Peer-median fwd P/E → $58; EV/Rev → $84.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| Scenario PWEV | $29 | 62% | $18 |
| Monte Carlo median | $27 | 37% | $10 |
| Triangulated | — | 100% | $28 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 5.6x | 6.8x | 8.0x | 9.2x | 10.4x |
|---|---|---|---|---|---|
| 8% | $3 | $5 | $8 | $10 | $13 |
| 8% | $2 | $4 | $7 | $9 | $12 |
| 10% | $1 | $3 | $6 | $8 | $10 |
| 10% | $0 | $2 | $5 | $7 | $9 |
| 12% | $-1 | $2 | $4 | $6 | $8 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $-6 | $-1 | $4 | $10 | $15 |
| -1.5pp | $-6 | $-1 | $5 | $11 | $16 |
| +0.0pp | $-6 | $-0 | $6 | $12 | $18 |
| +1.5pp | $-6 | $0 | $6 | $13 | $19 |
| +3.0pp | $-6 | $0 | $7 | $14 | $20 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Op margin ±3pp | $-6 | $18 | $24 |
| Terminal × ±15% | $3 | $8 | $5 |
| Revenue CAGR ±3pp | $4 | $7 | $3 |
| WACC ±1pp | $5 | $7 | $2 |
| FCF conversion ±10% | $6 | $6 | $0 |
Company lever — SoP/share vs Commodity Chemicals / Petrochemicals multiple (AI re-rating) (base 10x)
| Multiple | 7.0x | 8.5x | 10.0x | 11.5x | 13.0x |
|---|---|---|---|---|---|
| SoP/share | $360 | $441 | $523 | $604 | $686 |
Load-Bearing Assumptions
DCF: WACC 10%, terminal multiple 8×, FY+5 revenue $42B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
DCF $6 vs MC median $27 diverge by 79%. Investigate which assumptions differ. A miss on Gross Margin drops the case toward the structural target $7.69.
Fact / Inference / Speculation
- FACT: Spot $27; 52-week range $19–$42; engine rating HOLD; base-case target $29 (+7%).
- INFERENCE: Triangulated FV $28 (+4%). Gross Margin explains 64% of Monte Carlo outcome variance — the single variable that decides which side is right.
- SPECULATION: At current prices the embedded bet is that Gross Margin surprises to the upside — Gross Margin carries 64% of outcome variance.
Recommendation: HOLD
Balanced: triangulated fair value $22 (-18% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin (64% of variance) — a fundamental call. SBC runs —M TTM (disclosed in the appendix).